ES2175371T3 - Nuevos derivados de histidina, procedimiento de preparacion y su utilizacion como agentes anti-radicales libres. - Google Patents

Nuevos derivados de histidina, procedimiento de preparacion y su utilizacion como agentes anti-radicales libres.

Info

Publication number
ES2175371T3
ES2175371T3 ES97912295T ES97912295T ES2175371T3 ES 2175371 T3 ES2175371 T3 ES 2175371T3 ES 97912295 T ES97912295 T ES 97912295T ES 97912295 T ES97912295 T ES 97912295T ES 2175371 T3 ES2175371 T3 ES 2175371T3
Authority
ES
Spain
Prior art keywords
histidine
preparation procedure
new derivatives
free anti
radical agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97912295T
Other languages
English (en)
Inventor
Michel Philippe
Thierry Bordier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
L'Oréal SA
Original Assignee
L'Oréal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'Oréal SA filed Critical L'Oréal SA
Application granted granted Critical
Publication of ES2175371T3 publication Critical patent/ES2175371T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS DERIVADOS DE HISTIDINA QUE RESPONDEN A LA FORMULA GENERAL (I), EN LA QUE: R REPRESENTA UN RADICAL ALQUILO, LINEAL O RAMIFICADO, SATURADO O INSATURADO, QUE TIENEN ENTRE 6 Y 22 ATOMOS DE CARBONO, N ES UN NUMERO ENTERO QUE VA DE 1 A 16, Q + REPRESENTA H + O UN CATION ORGANICO O MINERAL Y LAS SALES DE ADICION CON UN ACIDO. LA INVENCION SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION DE LOS COMPUESTOS DE FORMULA (I) ASI COMO A SU UTILIZACION COSMETICA Y FARMACEUTICA.
ES97912295T 1996-12-04 1997-10-31 Nuevos derivados de histidina, procedimiento de preparacion y su utilizacion como agentes anti-radicales libres. Expired - Lifetime ES2175371T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614880A FR2756565B1 (fr) 1996-12-04 1996-12-04 Nouveaux derives d'histidine et leur utilisation en cosmetique ou en pharmacie

Publications (1)

Publication Number Publication Date
ES2175371T3 true ES2175371T3 (es) 2002-11-16

Family

ID=9498325

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97912295T Expired - Lifetime ES2175371T3 (es) 1996-12-04 1997-10-31 Nuevos derivados de histidina, procedimiento de preparacion y su utilizacion como agentes anti-radicales libres.

Country Status (10)

Country Link
US (2) US6255344B1 (es)
EP (1) EP0946516B1 (es)
JP (1) JP3233644B2 (es)
AT (1) ATE215934T1 (es)
AU (1) AU4953997A (es)
CA (1) CA2273989C (es)
DE (1) DE69711920T2 (es)
ES (1) ES2175371T3 (es)
FR (1) FR2756565B1 (es)
WO (1) WO1998024770A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756565B1 (fr) * 1996-12-04 1998-12-31 Oreal Nouveaux derives d'histidine et leur utilisation en cosmetique ou en pharmacie
FR2778917B1 (fr) * 1998-05-25 2000-06-30 Oreal Nouveaux derives d'histidine, procede de preparation et utilisations
FR2779060B1 (fr) 1998-05-26 2003-05-02 Oreal Association d'un retinoide avec un derive d'histidine
DE10207177A1 (de) * 2002-02-19 2003-09-04 Novosom Ag Fakultativ kationische Lipide
US6793193B2 (en) * 2002-08-20 2004-09-21 Dart Industries Inc. Adjustable mold for forming shaped food
US7420071B2 (en) * 2005-05-04 2008-09-02 Uchicago Argonne, Llc Thermally stable surfactants and compositions and methods of use thereof
KR102276326B1 (ko) * 2013-03-13 2021-07-13 앙테이스 에스.아. 피부 회춘을 위한 펩타이드 및 이것을 사용하는 방법
CN114891060B (zh) * 2022-07-13 2022-09-30 深圳湾实验室 关于蛋白质的光激活依赖性邻近标记方法及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57108072A (en) 1980-12-18 1982-07-05 Ajinomoto Co Inc Preparation of n-acylcarnosine
US4508728A (en) * 1984-05-24 1985-04-02 Kineshiro Nagai Method of treating inflammatory diseases
WO1990006102A1 (en) * 1988-09-28 1990-06-14 Peptide Technology Limited Compound and method for the retardation of collagen cross-linking
FR2661331A1 (fr) 1990-04-30 1991-10-31 Oreal Composition cosmetique ou dermopharmaceutique contenant des vesicules formees par un melange phospholipides/glycolipides.
FR2668365B1 (fr) * 1990-10-25 1994-12-23 Sederma Sa Utilisation en cosmetique des n-acetylpeptides dotes d'une activite biologique.
EP0510165B1 (fr) 1990-11-14 1995-01-25 L'oreal Composes amphiphiles non-ioniques derives du glycerol, leur procede de preparation, composes intermediaires correspondants et compositions contenant lesdits composes
WO1992009298A1 (en) 1990-11-23 1992-06-11 Peptide Technology Ltd. The delay, prevention and/or reversal of cell senescence
DE69225631T2 (de) * 1991-02-19 1998-12-17 Cci Corp., Gifu Acylaminosäure-Verbindungen und Verfahren zu ihrer Herstellung
FR2680373B1 (fr) 1991-08-12 1995-06-09 Bio Initiatives Procede de synthese enzymatique d'alpha-glucosides, alpha-glucosides ainsi obtenus, et utilisation de ces produits dans l'industrie cosmetique, pharmaceutique, agroalimentaire et chimique.
JP3154789B2 (ja) 1992-03-11 2001-04-09 ローム株式会社 サーマルヘッド駆動回路及びサーマルヘッド
FR2756565B1 (fr) * 1996-12-04 1998-12-31 Oreal Nouveaux derives d'histidine et leur utilisation en cosmetique ou en pharmacie
FR2778917B1 (fr) * 1998-05-25 2000-06-30 Oreal Nouveaux derives d'histidine, procede de preparation et utilisations
FR2779060B1 (fr) * 1998-05-26 2003-05-02 Oreal Association d'un retinoide avec un derive d'histidine

Also Published As

Publication number Publication date
US6255344B1 (en) 2001-07-03
EP0946516B1 (fr) 2002-04-10
US20020165165A9 (en) 2002-11-07
FR2756565B1 (fr) 1998-12-31
US6562789B2 (en) 2003-05-13
WO1998024770A1 (fr) 1998-06-11
FR2756565A1 (fr) 1998-06-05
JP2000505813A (ja) 2000-05-16
DE69711920T2 (de) 2002-08-08
JP3233644B2 (ja) 2001-11-26
ATE215934T1 (de) 2002-04-15
AU4953997A (en) 1998-06-29
CA2273989A1 (fr) 1998-06-11
DE69711920D1 (de) 2002-05-16
EP0946516A1 (fr) 1999-10-06
US20010031732A1 (en) 2001-10-18
CA2273989C (fr) 2003-10-21

Similar Documents

Publication Publication Date Title
ES2032456T3 (es) Procedimiento para preparar derivados de 1,2,5,6-tetrahidropiridin-3-carboxaldehido-oxima.
ES2052881T3 (es) Agentes reductores de la presion sanguinea.
ES2142034T3 (es) Compuestos biaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2085075T3 (es) Imidas y sus sales, asi como su uso como agentes tensioactivos.
ES2119325T3 (es) Compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2107762T3 (es) Utilizacion de un alquilester de glutation en una composicion cosmetica o dermatologica destinada al tratamiento por via topica del envejecimiento cutaneo.
ES2113024T3 (es) Alquilsiloxanos como adyuvantes para la agricultura.
ES2142798T3 (es) Derivados de 3-amido pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2110003T3 (es) Nuevas composiciones a base de derivados de la clase de los taxanos.
ES2039269T3 (es) Derivados de azolilmetil-ciclopropilo.
ES2033426T3 (es) Procedimiento para la preparacion de composiciones farmaceuticas de liberacion controlada que contienen 3'-azido-3'-desoxitimidina.
ES2087466T3 (es) Composiciones que contienen tensioactivos glicolipidos anionicos.
ES2065324T3 (es) N-(piridinil)-1h-indol-1-aminas, un procedimiento para su preparacion y su uso como medicamentos.
ES2143734T3 (es) Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2067154T3 (es) Dibenzoilalquilcianohidracinas.
ES2086771T3 (es) Composicion dermatologica y/o cosmetologica que contiene retinoides.
MX9307232A (es) Arilcicloalquilaminas n,n-disustituidas, sus sales, medicamentos que contiene estos compuestos y su empleo, asi como procedimientos para su preparacion.
ES2148458T3 (es) Derivados de fenil-4-tiazoles sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2104133T3 (es) Composiciones cosmeticas o farmaceuticas que contienen glicerofosfolipidos desacilados para uso topico.
ES2171722T3 (es) Nuevos derivados de la 5-o-desosaminil-6-o-metil-eritronolida a, su procedimiento de preparacion y su aplicacion a la preparacion de productos biologicamente activos.
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2172703T3 (es) Composiciones de fluoruro de perfluoro(alcoxiciclo alcano)carbonilo, y su uso.
ES2085739T3 (es) Compuestos anfifilos azufrados, fluorados y poliglicerolados, composicion cosmetica o farmaceutica que los contiene, procedimiento de preparacion y vesiculas formadas.
ES2105285T3 (es) Nuevos derivados de la adenosina, sus procedimientos de preparacion, composiciones farmaceuticas que los contienen.
ES2104461T3 (es) Composiciones cosmeticas que contienen una mezcla sinergica de polimeros acondicionadores.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 946516

Country of ref document: ES